http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101496834-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-332 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-9066 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 |
| filingDate | 2013-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101496834-B1 |
| titleOfInvention | Pharmaceutical compositions for the prevention and treatment of obesity containing biological active materials from Curcuma aromatica Salisb. extracts |
| abstract | The present invention relates to a pharmaceutical composition for the prevention and treatment of obesity, which comprises a physiologically active substance derived from ganoderma genus as an active ingredient. The pharmaceutical composition for preventing and treating obesity according to the present invention is characterized in that, among the diarylheptanoid- And curcumin lipolytic enzyme. Thus, the physiologically active substance derived from the ulegium of the present invention can be usefully used for prevention and treatment of obesity. |
| priorityDate | 2013-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.